Hypoxia-Inducible Factor Drives Vascularization of Modularly Assembled Engineered Tissue.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30585759.
- Also identified by DOI 10.1089/ten.TEA.2018.0294.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Using two inhibitory methods, we demonstrated that hypoxia-inducible factor (HIF) plays an important role in vascularizing and oxygenating modularly-assembled engineered tissues. Each inhibitory technique elucidated a different mechanism by which this occurred. Whereas systemic inhibition negatively impacted early recruitment of host-derived cells, genetic inhibition in grafted endothelial cells was detrimental to their survival. Taken together, our study suggests that methods of HIF-mediated mechanisms could be harnessed to tune the extent and rate of vascularization in engineered tissue constructs.
Medical subject headings
- Hypoxia-Inducible Factor 1, alpha Subunit
- Neovascularization, Physiologic
- Tissue Engineering